Cyclin D1 and cyclin E expression in malignant thyroid cells and in human thyroid carcinomas

International Journal of Cancer

Volumn 76, Issue 6, 1998, Pages 806-811

  Lazzereschi, Davide ^a   Sambuco, Laura ^a   Carnuvale Scalzo, Caterina ^a   Raniri, Annalisa ^b   Mincione, Gabriella ^b   Nardi, Francesco ^a   Colletta, Giulia ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN E;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; NONHUMAN; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYROID CARCINOMA; THYROID CELL;

ANIMALS; CELLS, CULTURED; CYCLIN D1; CYCLIN E; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; RATS; RNA, MESSENGER; THYROID GLAND; THYROID NEOPLASMS; THYROTROPIN;

EID: 0032503506     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980610)76:6<806::AID-IJC7>3.0.CO;2-1     Document Type: Article

References (33)

1. BARTKOVA, J., ZEMANOVA, M. and BARTEK, J., Abundance and subcellular localisation of cyclin D3 in human tumors, Int. J. Cancer, 65, 323-327 (1996).
2. BETTICHER, D.C., HEIGHWAY, J., THATCHER, N. and HASLETON, P.S., Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients. Brit. J. Cancer, 75, 1761-1768 (1997).
3. INK4A gene in human thyroid tumors and thyroid-tumor cell lines. Int. J. Cancer. 67, 29-34 (1996).
4. COLLETTA, G., CIRAFICI, A.M. and VECCHIO, G., Induction of the c-fos oncogene by thyrotropic hormone in ral thyroid cells in culture. Science, 233, 458-460 (1986).
5. COLLETTA, G., PINTO, A., Di FIORE, P.P., FERRENTINO, M.F., AVVEDIMENTO, V.E., TSUCHIDA, N. and VECCHIO, G., Dissociation between transformed and differentiated phenotype in rat thyroid epithelial cells after transformation with a temperature-sensitive muUint of the Kirsten murine sarcoma virus. Mol. cell Biol 3, 2099-2109 (1983).
6. COPPA, A., MINCIONE, G., LAZZERESCHI, D., RANIERI, A., TURCO, A., LUCIGNANO, B., SCARPA, S., RAGANO-CARACCIOLO, M. and COLLETTA, G., The restored expression of transforming growth factor β type II receptor in K-ras transformed thyroid cells, TGFβ-resistant, reverts their malignant phenptype. J. cell. Physiol., 172, 200-208 (1997).
7. COPPA, A., MINCIONE, G., MAMMARELLA, S., RANIERI, A. and COLLETTA, G., Epithelial rat thyroid cell clones, escaping from TGFβ negative growth control, are still inhibited by this factor in the ability to trap iodide. Cell Growth Differentiation, 6, 583-587 (1995).
8. DE BOER, C.J., VAN KRIEKEN, J.H., KLUIN-NELEMANS, H.C., KLUIN, P.M. and SCHLUURING, E., Cyclin D1 messenger RNA overexpression as marker for mantle cell lymphoma, Oncogene, 10, 1833-1840 (1995).
9. FARID, N.R., SHY, Y. and Zou, M., The molecular biology of thyroid cancer. Entfacrinol Rev., 15, 202-232 (1994).
10. FILMUS, J., ROBLES, A.I., SHI, W., WONG, M.J., COLOMBO, L.L. and CONTI, C.J., Induction of cyclin D1 overexpression by activated ras. Oncogene, 9, 3627-3633 (1994).
11. 1 cyclins and cyclin-dependent protein kinases. Proc. nut. Acad. Sci. (Wttsh.), 90, 10315-10319 (1993).
12. HALL, M. and PETERS, G., Genetic alterations of cyclins, cyclin-dependent kinases. and cdk inhibitors in human cancer. Adv. Cancer Res., 68, 67-108 (1996).
13. HUNTER, T. and PINES, J., Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79, 573-582 (1994).
14. JIANG, W., KAHN, S.M., ZHOU, P., ZHANG, Y.J., CACACE, A.M., INFANTE, A.S., Doi, S., SANTELLA, R.M. and WEINSTEIN, I.B., Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8, 3447-3457 (1993).
15. KATOH, R., BRAY, C.E., SUZUKI, K., KOMIYAMA, A., HEMMI, A., KAWAOI, A., OYAMA, T., SUGAI, T. and SASOU, S., Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Hum. Pathol., 26, 139-146 (1995).
16. KEYOMARSI, K. and PARDEE, A.B., Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. nat. Acad. Sci. (Wash.), 90, 1112-1116 (1994).
17. LAZZERESCHI, D., RANIERI, A., MINCIONE, G., TACCOGNA. S., NARDI, F. and COLLETTA, G., Human malignant thyroid tumors displayed reduced levels ot TGFβ receptor type II mRNA and protein. Cancer Res., 57, 2071-2076 (1997).
18. LUKAS, J., PAGANO, M., STASKOVA, Z., DRAETTA, G. and BARTEK, J., Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene, 9, 707-718 (1994).
19. 1 phase of the cell cycle. Cell, 65, 701-713 (1991).
20. MlCHALIDES, R., VAN VEELEN. N., HART, A., LOFTUS, B., WIENTJENS, E. and BALM, A., Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res., 55, 975-978 (1995).
21. MINCIONE, G., CIRAFICI, A.M., LAZZERESCHI, D., PUPI, S., CIARDIELLO, F. and COLLETTA, G., Loss of thyrotropin regulation and transforming growth factor β-induced growth arrest in ErhB-2 overexpressing rat thyroid cells. Cancer Res., 53, 5548-5553 (1993).
22. MOTOKURA, T., BLOOM, T., KIM, H.G., JÜPPNER, H., RUDERMAN, J.V., KRONUNBERG, H.M. and ARNOLD, A., A novel cyclin encoded by a bcl-linked candidate oncogene. Nature (Lond.), 350, 512-515 (1991).
23. NIELSEN, N.H., EMDIN, S.O., CAJANDER, J. and LANDBERG, G., Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene, 14, 295-304 (1997).
24. 1-to-S phase transition. Mol. cell. Biol., 15, 2612-2624 (1995).
25. OKAMOTO, A., JIANG, W., KIM, S., SPILLARE, E.A., STONER, G.D., WEINSTEIN, I.B. and HARRIS, C.C., Overexprcssion of human cyclin D1 reduces the transforming growth factor β (TGF-β) type II receptor and growth inhibition by TGF-β l in an immortulized human esophageal epithelial cell line. Proc. nat. Acad. Sci. (Wash.), 91, 11576-11580 (1994).
26. PORTER, P.L., MALONE, K.E., HEAGERTY, P.J., ALEXANDER, G.M., GATTI, L.A., FIRPO, E.J., DALING, J.R. and ROBERTS, J.M., Expression of cell-cycle regulators p27kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature (Med.), 3, 222-227 (1997).
27. 1 phase progression: cycling on clue. Cell, 79, 551-555 (1994).
28. SHERR, C.J., Cancer cell cycles. Science, 274, 1672-1677 (1996).
29. WEINBERG. R.A., The retinoblastoma protein and cell cycle control, Cell, 81, 323-330 (1995).
30. WITHERS, D.A., HARVEY, R.C., FAUST, J.B., MELNYK, O., CAREY, K. and MEEKER, T.C., Characterization of a candidate bcl-1 gene. Mol. cell. Biol., 11, 4846-4853 (1991).
31. 1 phase after insulin-like growth factor I stimulation in FRTL-5 cells. Endocrinology, 137, 2036-2042 (1996).
32. ZHANG, S.Y., CAAMANO, J., COOPER, F., Guo, X. and KLEIN-SZANTO, A.J.P., Immunohistochemistry of cyclin D1 in human breast cancer. Amen J. clin. Pathol., 102, 695-698 (1994).
33. ZHANG, T., NANNEY, L.B., PEELER, M.O., WILLIAMS, C.S., LAMPS, L., HEPPNER, K.J., DuBois, R.N. and BLAUCHAMP, R.D., Decreased transforming growth factor β type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression. Cancer Res., 57, 1638-1643 (1997).